青少年非酒精性脂肪性肝病与成年早期2型糖尿病风险
这项基于以色列全国人群的研究纳入1 025 796名血糖正常的青少年,随访至2016年底,评估青少年期非酒精性脂肪性肝病(NAFLD)与后续2型糖尿病风险的关系。在中位随访13.3年间,NAFLD组2型糖尿病发生率为1.9%,非NAFLD组为0.3%;调整BMI和社会人口学混杂因素后,NAFLD组2型糖尿病风险显著升高(HR 2.59,95%CI 1.47-4.58)。
要点
- 青少年NAFLD与成年早期2型糖尿病风险升高独立相关,调整BMI后HR为2.59。
- NAFLD组2型糖尿病发生率为1.9%,非NAFLD组为0.3%。
- 风险在30岁前即可显现,且在无其他代谢合并症者中持续存在。
核心结论
- 在血糖正常的青少年中,NAFLD与调整后2型糖尿病风险升高相关,且该风险可能在30岁前即可显现。
研究设计与样本
- 全国性、基于人群的队列研究,纳入1997-2011年间服役前体检的以色列青少年,随访至2016年12月31日。
- 共纳入1 025 796名血糖正常的青少年,NAFLD诊断需活检或影像学检查,数据与以色列国家糖尿病登记处链接。
主要发现
- 平均随访13.3年,633名NAFLD青少年中12名(1.9%)诊断为2型糖尿病,均基线BMI高;非NAFLD组2917名(0.3%)诊断为2型糖尿病。
- 调整BMI和社会人口学混杂因素后,NAFLD组对比非NAFLD组的2型糖尿病风险比(HR)为2.59(95%CI 1.47-4.58)。
- 在无其他代谢合并症者中调整后HR为2.75(95%CI 1.48-5.14);以30岁前诊断2型糖尿病为结局的调整后HR为2.14(95%CI 1.02-4.52)。
- 以性别、出生年份和BMI匹配的对照组为参照时,调整后HR为2.98(95%CI 1.54-5.74)。
临床怎么用
- 对血糖正常的青少年NAFLD患者,应关注其远期2型糖尿病风险,即使BMI正常或尚无其他代谢合并症。
- 青少年NAFLD患者可能需要长期血糖监测,尤其关注30岁前的糖尿病发生。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: The long-term risk of type 2 diabetes in adolescents with nonalcoholic fatty liver disease (NAFLD) is unclear. OBJECTIVE: To assess type 2 diabetes risk among adolescents with NAFLD. DESIGN AND SETTING: A nationwide, population-based study of Israeli adolescents who were examined before military service during 1997-2011 and were followed until December 31, 2016. PARTICIPANTS: A total of 1 025 796 normoglycemic adolescents were included. INTERVENTIONS: Biopsy or radiographic tests were prerequisite for NAFLD diagnosis. Data were linked to the Israeli National Diabetes Registry. MAIN OUTCOME MEASURES: Type 2 diabetes incidence. RESULTS: During a mean follow-up of 13.3 years, 12 of 633 adolescents with NAFLD (1.9%; all with high body mass index [BMI] at baseline) were diagnosed with type 2 diabetes compared with 2917 (0.3%) adolescents without NAFLD. The hazard ratio (HR) for type 2 diabetes was 2.59 (95% confidence interval [CI], 1.47-4.58) for the NAFLD vs. the non-NAFLD group after adjustment for BMI and sociodemographic confounders. The elevated risk persisted in several sensitivity analyses. These included an analysis of persons without other metabolic comorbidities (adjusted HR, 2.75 [95% CI, 1.48-5.14]) and of persons with high BMI; and an analysis whose outcome was type 2 diabetes by age 30 years (adjusted HR, 2.14 [95% CI, 1.02-4.52]). The results remained significant when a sex-, birth year-, and BMI-matched control group was the reference (adjusted HR, 2.98 [95% CI, 1.54-5.74]). CONCLUSIONS: Among normoglycemic adolescents, NAFLD was associated with an increased adjusted risk for type 2 diabetes, which may be apparent before age 30 years.
引用
- Bardugo A, Bendor CD, Zucker I, et al. Adolescent Nonalcoholic Fatty Liver Disease and Type 2 Diabetes in Young Adulthood. J Clin Endocrinol Metab. 2021. PMID: 33075820. doi:10.1210/clinem/dgaa753
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。